Last update 01 Nov 2024

Guang Zhou Han Ke Sheng Wu You Xian Gong Si

Private Company|
2023|
Guangdong Sheng, China

Overview

Tags

Immune System Diseases
Hemic and Lymphatic Diseases
Neoplasms
Immune cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Immune System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Immune cell therapy1
Top 5 TargetCount
CD47 x SIRPα1

Related

1
Drugs associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
HCB101
Target
CD47 x SIRPα
Mechanism
CD47 modulators [+1]
Active Org.
Guang Zhou Han Ke Sheng Wu You Xian Gong Si [+1]
Originator Org.
HanchorBio incHanchorBio inc
Active Indication
Non-Hodgkin Lymphoma [+4]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
CTR20242880 / Not yet recruitingPhase 1
一项评估HCB101注射液在晚期实体肿瘤及复发难治非霍奇金淋巴瘤的安全性、耐受性、药物动力学及抗肿瘤活性的开放标签、多中心、剂量递增的临床I期试验
[Translation] An open-label, multicenter, dose-escalation Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and anti-tumor activity of HCB101 injection in advanced solid tumors and relapsed and refractory non-Hodgkin's lymphoma
100 Clinical Results associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
Login to view more data
0 Patents (Medical) associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
Login to view more data
100 Deals associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
Login to view more data
100 Translational Medicine associated with Guang Zhou Han Ke Sheng Wu You Xian Gong Si
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HCB101
 ( CD47 x SIRPα )		Non-Hodgkin Lymphoma
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free